Keiichi Kontani

7610793, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Status and prognostic value of immunological biomarkers of breast cancer.

Status and prognostic value of immunological biomarkers of breast cancer.

Journal: Oncology letters

Published: October 21, 2022

Association of longer telomere length in cancer cells and cancer-associated fibroblasts with worse prognosis.

Association of longer telomere length in cancer cells and cancer-associated fibroblasts with worse prognosis.

Journal: Journal of the National Cancer Institute

Published: April 09, 2022

Phosphorylation of hTERT at threonine 249 is a novel tumor biomarker of aggressive cancer with poor prognosis in multiple organs.

Phosphorylation of hTERT at threonine 249 is a novel tumor biomarker of aggressive cancer with poor prognosis in multiple organs.

Journal: The Journal of pathology

Published: August 27, 2021

Clinicopathological characteristics and prognostic marker of triple-negative breast cancer in older women.

Clinicopathological characteristics and prognostic marker of triple-negative breast cancer in older women.

Journal: Human pathology

Published: November 30, 2020

Efficacy of TS-1 as a Late-Line Treatment for Metastatic Breast Cancer

Efficacy of TS-1 as a Late-Line Treatment for Metastatic Breast Cancer

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: September 19, 2019

Utility of Prophylactic Administration of Pegfilgrastim in Breast Cancer Chemotherapy

Utility of Prophylactic Administration of Pegfilgrastim in Breast Cancer Chemotherapy

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: December 28, 2018

Hypertension and Proteinuria as Predictive Factors of Effects of Bevacizumab on Advanced Breast Cancer in Japan.

Hypertension and Proteinuria as Predictive Factors of Effects of Bevacizumab on Advanced Breast Cancer in Japan.

Journal: Biological & pharmaceutical bulletin

Published: April 03, 2018

Candidate biomarkers predictive of anthracycline and taxane efficacy against breast cancer.

Candidate biomarkers predictive of anthracycline and taxane efficacy against breast cancer.

Journal: Journal of cancer research and therapeutics

Published: March 09, 2018

Predictive biomarkers and effectiveness of MUC1-targeted dendritic-cell-based vaccine in patients with refractory non-small cell lung cancer.

Predictive biomarkers and effectiveness of MUC1-targeted dendritic-cell-based vaccine in patients with refractory non-small cell lung cancer.

Journal: Therapeutic advances in medical oncology

Published: March 28, 2017

Retrospective analysis of the survival benefit of chemotherapy for recurrent or advanced epithelial ovarian carcinoma in patients previously treated with paclitaxel plus platinum-based chemotherapy.

Retrospective analysis of the survival benefit of chemotherapy for recurrent or advanced epithelial ovarian carcinoma in patients previously treated with paclitaxel plus platinum-based chemotherapy.

Journal: European journal of gynaecological oncology

Published: August 01, 2016

Indication of metronomic chemotherapy for metastatic breast cancer: Clinical outcomes and responsive subtypes.

Indication of metronomic chemotherapy for metastatic breast cancer: Clinical outcomes and responsive subtypes.

Journal: Molecular and clinical oncology

Published: January 20, 2016

Factors responsible for long-term survival in metastatic breast cancer.

Factors responsible for long-term survival in metastatic breast cancer.

Journal: World journal of surgical oncology

Published: January 30, 2014

Showing 1-12 of 18

Last Updated: 09/26/2026